GAMCO INVESTORS, INC. ET AL - OSIRIS THERAPEUTICS INC NEW ownership

OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 59 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 99.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
GAMCO INVESTORS, INC. ET AL ownership history of OSIRIS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$914,000
-3.3%
48,099
-31.3%
0.01%
-12.5%
Q4 2018$945,000
+21.6%
69,9990.0%0.01%
+60.0%
Q3 2018$777,00069,9990.01%
Other shareholders
OSIRIS THERAPEUTICS INC NEW shareholders Q1 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,240,709$23,259,0003.12%
PRINCETON CAPITAL MANAGEMENT INC 34,825$361,0000.25%
Freedom Investment Management, Inc. 118,284$1,228,0000.09%
Spark Investment Management LLC 62,800$651,0000.08%
GSA CAPITAL PARTNERS LLP 98,901$1,027,0000.05%
Baker Brothers Advisors 499,193$5,182,0000.04%
KILLEN GROUP INC 31,000$322,0000.03%
GROUP ONE TRADING, L.P. 127,263$1,321,0000.02%
A.R.T. Advisors, LLC 27,049$280,0000.01%
QS Investors, LLC 132,027$1,370,0000.01%
View complete list of OSIRIS THERAPEUTICS INC NEW shareholders